BeOne Medicines AG
ONC | NASDAQ
$387.25
+$9.47 (+2.51%)
At close: Nov 5, 2026, 4:00 PM ET
$380.00
-$7.25 (-1.87%)
After-hours:
Nov 5, 2026, 5:12 PM ET
Market Data
Market Cap $41.38B
Enterprise Value $36.41B
Beta 0.52
Average Volume 380.47K
Shares Outstanding (Diluted) 115.8M
Shares Change YoY 2.61%
Institutional Ownership 31.34%
Exchange NASDAQ
ISIN US07725L1026
Price Performance
Price Change 1M 6.8%
Price Change 3M 17.4%
Price Change 6M 22.2%
Price Change YTD 27.5%
Price Change 1Y 16.5%
Price Change 3Y 97.4%
Price Change 5Y 6.1%
1M CAGR (ann.) -1.2%
1Y CAGR (ann.) 17.2%
5Y CAGR (ann.) -1.4%
All-Time CAGR 26.9%
Valuation
PE Ratio 5.23
Forward PE 36.75
PEG Ratio -0.41
Forward PEG 0.19
PS Ratio 6.59
Forward PS 5.20
PB Ratio 7.80
P/FCF Ratio 32.49
P/Adj. FCF Ratio 480.88
P/OCF Ratio 25.95
EV/Sales 5.94
EV/EBIT 36.25
EV/EBITDA 31.41
EV/FCF 29.30
Earnings Yield 19.1%
FCF Yield 3.1%
Adj. FCF Yield 0.2%
Financial Health
Net Cash $4.02B
Total Debt $1.14B
Cash & Short-Term Investments $5.1B
Total Assets $9.18B
Current Ratio 3.40
Quick Ratio 3.06
Debt / Equity Ratio 0.22
Debt / EBITDA 0.99
Debt / FCF 0.92
OCF / Debt 1.47
Interest Coverage 9.90
Altman Z-Score 6.55
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 87.8%
Operating Profit Margin 15.1%
EBITDA Margin 18.2%
Net Profit Margin 10.7%
FCF Margin 20.3%
Adj. FCF Margin 1.4%
SBC / Revenue 8.5%
SBC Impact (per share) -93.2%
Returns
Return on Assets 7.2%
Return on Equity 14.3%
Return on Invested Capital 9.6%
Return on Capital Employed 13.1%
Return on Tangible Assets 7.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 50.1%
Revenue CAGR 5Y 45.3%
Revenue CAGR 10Y 96.5%
EPS CAGR 3Y 343.6%
EPS CAGR 5Y 569.6%
EPS CAGR 10Y 45.0%
FCF CAGR 3Y 7592.1%
FCF CAGR 5Y 105.5%
FCF CAGR 10Y 6.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y -40.4%
Revenue Growth Next 3Y 17.0%
Earnings Date Nov 5, 2026
EPS Estimate (next Q) $1.90
EPS Growth Est (next Q) 74.3%
Revenue Est (next Q) $1.76B
Revenue Growth Est (next Q) 24.5%
Fair Value Estimates
Graham Number $269.56
Graham Upside -28.6%
Lynch Fair Value $1,807.00
Lynch Upside 378.3%
Price Target $406.22
Price Target Upside 7.5%
Cash Flow
Operating Cash Flow $1.69B
Free Cash Flow $1.24B
Adj. Free Cash Flow $83.95M
FCF Per Share $10.73
OCF Per Share $14.56
OCF/S Ratio 24.2%
Income Statement
Revenue $6.13B
Gross Profit $5.45B
Operating Income $923.1M
EBITDA $1.16B
Net Income $655.71M
EPS (Diluted) $72.28
Revenue / Employee $510.75K
Profit / Employee $54.64K
Employees 12,000
Add to Watchlist
Select watchlists to add or remove ONC